WS Investor
04 Jun 2026, 18:04
UnitedHealth Jumps as Bank of America Upgrades Stock and Analysts Raise Targets
UnitedHealth Group (UNH) shares surged more than 5% after receiving a significant vote of confidence from Wall Street. Bank of America upgraded the healthcare giant from Neutral to Buy while raising its price target from $420 to $450, signaling growing optimism about the company's outlook.
Adding to the positive sentiment, Morgan Stanley also raised its price target from $395 to $453 while maintaining its Overweight rating. The dual analyst actions suggest that concerns surrounding the company may be easing and that valuation has become increasingly attractive following the stock's sharp decline last year. With shares trading around $397, both firms now see meaningful upside potential from current levels.
Today's strong rally reflects investors embracing the more constructive Wall Street outlook. The combination of an analyst upgrade and multiple price target increases suggests sentiment may be turning more favorable for one of the largest healthcare companies in the world after a difficult period for the stock.
UnitedHealth Group (UNH) shares surged more than 5% after receiving a significant vote of confidence from Wall Street. Bank of America upgraded the healthcare giant from Neutral to Buy while raising its price target from $420 to $450, signaling growing optimism about the company's outlook.
Adding to the positive sentiment, Morgan Stanley also raised its price target from $395 to $453 while maintaining its Overweight rating. The dual analyst actions suggest that concerns surrounding the company may be easing and that valuation has become increasingly attractive following the stock's sharp decline last year. With shares trading around $397, both firms now see meaningful upside potential from current levels.
Today's strong rally reflects investors embracing the more constructive Wall Street outlook. The combination of an analyst upgrade and multiple price target increases suggests sentiment may be turning more favorable for one of the largest healthcare companies in the world after a difficult period for the stock.
